A detailed history of American Century Companies Inc transactions in Amgen Inc stock. As of the latest transaction made, American Century Companies Inc holds 262,708 shares of AMGN stock, worth $77.4 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
262,708
Previous 312,542 15.94%
Holding current value
$77.4 Million
Previous $97.7 Million 13.32%
% of portfolio
0.05%
Previous 0.06%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$309.38 - $337.38 $15.4 Million - $16.8 Million
-49,834 Reduced 15.94%
262,708 $84.6 Million
Q2 2024

Aug 07, 2024

SELL
$262.75 - $319.31 $9.62 Million - $11.7 Million
-36,599 Reduced 10.48%
312,542 $97.7 Million
Q1 2024

May 14, 2024

SELL
$268.87 - $324.56 $651,740 - $786,733
-2,424 Reduced 0.69%
349,141 $99.3 Million
Q4 2023

Feb 13, 2024

BUY
$255.7 - $288.46 $89.9 Million - $101 Million
351,565 New
351,565 $101 Million
Q3 2023

Nov 13, 2023

BUY
$218.65 - $271.46 $512,952 - $636,845
2,346 Added 0.71%
335,086 $90.1 Million
Q2 2023

Aug 14, 2023

SELL
$214.27 - $253.37 $13.9 Million - $16.4 Million
-64,733 Reduced 16.29%
332,740 $73.9 Million
Q1 2023

May 11, 2023

BUY
$225.79 - $275.2 $13.6 Million - $16.6 Million
60,268 Added 17.87%
397,473 $96.1 Million
Q4 2022

Feb 13, 2023

SELL
$229.03 - $291.01 $9.54 Million - $12.1 Million
-41,671 Reduced 11.0%
337,205 $88.6 Million
Q3 2022

Nov 14, 2022

BUY
$224.46 - $253.15 $11.2 Million - $12.6 Million
49,828 Added 15.14%
378,876 $85.4 Million
Q2 2022

Aug 12, 2022

SELL
$230.71 - $256.74 $66.2 Million - $73.6 Million
-286,820 Reduced 46.57%
329,048 $80.1 Million
Q1 2022

May 11, 2022

BUY
$219.27 - $242.57 $10.2 Million - $11.3 Million
46,705 Added 8.21%
615,868 $149 Million
Q4 2021

Feb 07, 2022

SELL
$198.88 - $227.6 $6.8 Million - $7.78 Million
-34,187 Reduced 5.67%
569,163 $128 Million
Q3 2021

Nov 10, 2021

BUY
$212.27 - $248.7 $1.8 Million - $2.11 Million
8,477 Added 1.43%
603,350 $128 Million
Q2 2021

Aug 05, 2021

SELL
$233.58 - $259.14 $60.1 Million - $66.7 Million
-257,479 Reduced 30.21%
594,873 $145 Million
Q1 2021

May 14, 2021

SELL
$221.91 - $258.6 $75.6 Million - $88.1 Million
-340,502 Reduced 28.55%
852,352 $212 Million
Q4 2020

Feb 12, 2021

SELL
$216.38 - $257.67 $1.88 Million - $2.24 Million
-8,674 Reduced 0.72%
1,192,854 $274 Million
Q3 2020

Nov 13, 2020

SELL
$234.65 - $260.95 $10.5 Million - $11.7 Million
-44,655 Reduced 3.58%
1,201,528 $305 Million
Q2 2020

Aug 13, 2020

BUY
$197.81 - $242.74 $187 Million - $229 Million
943,323 Added 311.47%
1,246,183 $294 Million
Q1 2020

May 14, 2020

SELL
$182.24 - $241.7 $5.31 Million - $7.04 Million
-29,117 Reduced 8.77%
302,860 $61.4 Million
Q4 2019

Feb 12, 2020

SELL
$189.21 - $243.2 $40.8 Million - $52.4 Million
-215,477 Reduced 39.36%
331,977 $80 Million
Q3 2019

Nov 13, 2019

BUY
$174.11 - $208.62 $7.4 Million - $8.86 Million
42,490 Added 8.41%
547,454 $106 Million
Q2 2019

Aug 14, 2019

SELL
$166.7 - $195.41 $34.4 Million - $40.3 Million
-206,295 Reduced 29.0%
504,964 $93.1 Million
Q1 2019

May 14, 2019

SELL
$180.87 - $203.88 $11.9 Million - $13.5 Million
-66,058 Reduced 8.5%
711,259 $0
Q4 2018

Feb 13, 2019

SELL
$178.4 - $208.25 $12.5 Million - $14.6 Million
-70,020 Reduced 8.26%
777,317 $151 Million
Q3 2018

Nov 02, 2018

BUY
$185.29 - $208.89 $1.51 Million - $1.7 Million
8,133 Added 0.97%
847,337 $176 Million
Q2 2018

Aug 08, 2018

SELL
$166.05 - $186.51 $125 Million - $140 Million
-750,418 Reduced 47.21%
839,204 $155 Million
Q1 2018

May 03, 2018

SELL
$169.43 - $198.0 $20 Million - $23.3 Million
-117,892 Reduced 6.9%
1,589,622 $271 Million
Q4 2017

Feb 02, 2018

BUY
$168.79 - $188.59 $72.5 Million - $81 Million
429,748 Added 33.63%
1,707,514 $297 Million
Q3 2017

Nov 01, 2017

BUY
$167.29 - $191.0 $214 Million - $244 Million
1,277,766
1,277,766 $238 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.